MARC-42 is an AHRQ-funded analysis of large administrative datasets (i.e., Medicare and State Inpatient Databases) and survey data (i.e., NHANES and MCBS) to investigate readmissions within 30 days after COPD-related hospitalization and comparative effectiveness in COPD management.
Please contact Drs. Carlos Camargo or Kohei Hasegawa if you would like additional details.
- Hasegawa K, Gibo K, Tsugawa Y, Shimada YJ, Camargo CA Jr. Age-related differences in the rate, timing, and diagnosis of 30-day readmissions in hospitalized adults With asthma exacerbation. Chest 2016. PMID: 26836926
- Goto T, Faridi MK, Gibo K, Toh S, Hanania NA, Camargo CA Jr, Hasegawa K. Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med 2017. PMID: 29206640
- Goto T, Faridi MK, Gibo K, Camargo CA Jr, Hasegawa K. Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization. Respir Med 2017. PMID: 28947044
- Goto T, Faridi MK, Camargo CA Jr., Hasegawa K. Time-varying readmission diagnoses during 30 days after hospitalization for COPD exacerbation. Med Care 2018. PMID: 29912841